Status:
RECRUITING
TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients
Lead Sponsor:
Children's Hospital Medical Center, Cincinnati
Conditions:
Hematopoietic Stem Cell Transplant (HSCT)
Diffuse Alveolar Hemorrhage
Eligibility:
All Genders
Up to 24 years
Brief Summary
Hematopoietic stem cell transplant (HSCT) is an effective but toxic therapy and pulmonary morbidity affects as many as 25% of children receiving transplant. Early pulmonary injury includes diffuse alv...
Eligibility Criteria
Inclusion
- Subjects ≤ 24 years of age undergoing allogeneic or autologous HSCT.
Exclusion
- Subjects over 24 years of age.
Key Trial Info
Start Date :
September 8 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2036
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT04098445
Start Date
September 8 2021
End Date
September 1 2036
Last Update
July 15 2025
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California San Francisco
San Francisco, California, United States, 94158
2
Children's Hospital Colorado
Aurora, Colorado, United States, 80045
3
Dana-Farber Cancer Institute/Boston Children's Hospital
Boston, Massachusetts, United States, 02215
4
University of Minnesota
Minneapolis, Minnesota, United States, 55455